In accordance, BMP7v significantly reduced the percentage of cells expressing the CD133/CD44v6 CSC markers and increased the number of CDX2+ cells within CRC spheres (Fig. 2c, d and Supplementary Fig. 2e, f). This evidence concerns the gene CDX2 and colorectal carcinoma.